AptarGroup Inc. (ATR)
undefined
undefined%
At close: undefined
152.92
0.14%
After-hours Jan 06, 2025, 07:00 PM EST

AptarGroup Inc. Revenue Breakdown

Quarter Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012Mar 31, 2012Dec 31, 2011Sep 30, 2011
Beauty And Home Revenue 339.17M 359.82M 371.35M 368.20M 374.09M 360.25M 346.95M 337.23M 299.79M 324.56M 314.79M 328.18M 342.08M 367.66M 337.91M 227.51M 368.54M 378.17M 335.47M 333.75M 322.12M 322.45M 290.40M 316.03M 340.32M 314.34M 302.77M 321.64M 319.12M 329.41M 342.93M 378.90M 391.38M 388.70M 1.42B 344.72M 365.99M 337.79M 1.18B 312.09M 266.07M 280.40M 830.33M 136.20M
Beauty And Home Revenue Growth -5.74% -3.10% +0.85% -1.57% +3.84% +3.83% +2.88% +12.49% -7.63% +3.10% -4.08% -4.06% -6.96% +8.80% +48.52% -38.27% -2.55% +12.73% +0.52% +3.61% -0.10% +11.04% -8.11% -7.14% +8.27% +3.82% -5.87% +0.79% -3.12% -3.94% -9.49% -3.19% +0.69% -72.58% +311.23% -5.81% +8.35% -71.31% +277.21% +17.30% -5.11% -66.23% +509.63% n/a
Food + Beverage Revenue 121.58M 133.64M 132.97M 134.27M 138.13M 125.44M 115.98M 315.76M 301.26M 297.20M 267.16M 269.25M 281.94M 272.70M 255.80M 341.76M 241.21M 230.13M 207.72M 199.55M 201.70M 196.91M 176.11M 191.19M 191.03M 183.13M 174.82M 175.43M 183.30M 178.67M 182.00M 179.19M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 293.04M
Food + Beverage Revenue Growth -9.02% +0.51% -0.97% -2.79% +10.11% +8.16% -63.27% +4.81% +1.37% +11.24% -0.78% -4.50% +3.39% +6.61% -25.15% +41.69% +4.82% +10.79% +4.10% -1.07% +2.43% +11.81% -7.89% +0.08% +4.31% +4.75% -0.34% -4.30% +2.59% -1.83% +1.57% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pharma Revenue 335.17M 343.40M 340.23M 342.46M 313.23M 325.34M 313.83M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pharma Revenue Growth -2.40% +0.93% -0.65% +9.33% -3.72% +3.67% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011
China Revenue 152.61M 156.58M 906.06M 854.64M 1.64B 1.63B 1.43B 1.33B 1.29B 1.51B 1.45B 1.27B 1.34B
China Revenue Growth -2.53% -82.72% +6.02% -47.84% +0.68% +14.12% +7.28% +3.27% -14.58% +3.78% +14.40% -5.28% n/a
Europe Revenue 2.00B 1.77B 486.93M n/a 149.08M 146.70M 132.99M 120.23M 122.55M 150.47M 810.53M 650.23M 630.17M
Europe Revenue Growth +12.88% +264.20% n/a n/a +1.62% +10.31% +10.62% -1.89% -18.56% -81.44% +24.65% +3.18% n/a
France Revenue 1.08B 938.64M 161.68M n/a 384.50M 410.95M 400.95M 381.72M 396.32M 448.76M 339.86M 311.20M 308.85M
France Revenue Growth +14.81% +480.57% n/a n/a -6.44% +2.49% +5.04% -3.68% -11.69% +32.04% +9.21% +0.76% n/a
Germany Revenue 564.53M 512.71M 170.52M n/a n/a n/a n/a n/a n/a n/a 136.62M 144.16M 168.88M
Germany Revenue Growth +10.11% +200.67% n/a n/a n/a n/a n/a n/a n/a n/a -5.23% -14.64% n/a
Italy Revenue 172.22M 154.82M 420.22M n/a n/a n/a n/a n/a n/a n/a 165.04M 163.69M 232.13M
Italy Revenue Growth +11.23% -63.16% n/a n/a n/a n/a n/a n/a n/a n/a +0.82% -29.48% n/a
Other Europe Revenue 187.34M 167.23M 1.08B n/a n/a n/a n/a n/a n/a n/a 433.55M 411.11M 361.09M
Other Europe Revenue Growth +12.03% -84.54% n/a n/a n/a n/a n/a n/a n/a n/a +5.46% +13.85% n/a
Other Foreign Countries Revenue 331.98M 292.12M n/a n/a n/a n/a n/a n/a n/a n/a 634.42M 650.64M 636.06M
Other Foreign Countries Revenue Growth +13.64% n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.49% +2.29% n/a
United States Revenue 1.00B 1.10B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth -9.01% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 141.60M 145.93M 152.78M 138.29M 138.14M 141.43M 147.92M 127.91M 135.43M 135.38M 145.54M 140.05M 135.93M 140.91M 134.35M 128.82M 121.85M 123.36M 126.19M 108.09M 111.56M 113.75M 121.22M 106.81M 103.57M 107.11M 112.46M 95.36M 95.75M 95.66M 101.52M 81.72M 86.69M 96.13M 103.02M 84.59M 81.37M 89.31M 96.19M
Selling, General, and Administrative Revenue Growth -2.96% -4.48% +10.47% +0.11% -2.33% -4.39% +15.65% -5.55% +0.03% -6.98% +3.92% +3.03% -3.54% +4.89% +4.29% +5.72% -1.23% -2.24% +16.75% -3.11% -1.93% -6.16% +13.49% +3.12% -3.30% -4.76% +17.94% -0.41% +0.09% -5.77% +24.22% -5.74% -9.82% -6.68% +21.78% +3.96% -8.89% -7.15% n/a
Research and Development Revenue n/a 149.33M 152.78M 138.29M 138.14M 141.43M 147.92M 127.91M 135.43M 135.38M 145.54M 140.05M 135.93M 140.91M n/a 140.05M 121.85M 123.36M n/a 82.80M 111.56M 113.75M n/a 75.30M 103.57M 107.11M n/a 68.20M 95.75M 95.66M n/a 66.20M 86.69M 96.13M n/a 67.10M 81.37M 89.31M n/a
Research and Development Revenue Growth -100.00% -2.26% +10.47% +0.11% -2.33% -4.39% +15.65% -5.55% +0.03% -6.98% +3.92% +3.03% -3.54% n/a -100.00% +14.94% -1.23% n/a -100.00% -25.78% -1.93% n/a -100.00% -27.30% -3.30% n/a -100.00% -28.77% +0.09% n/a -100.00% -23.64% -9.82% n/a -100.00% -17.54% -8.89% n/a n/a

Create Price Alert on ATR

Your price alert will notify you when the stock price is above 152.71.

Add to Watchlist